Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
Yearby
Ruqaiijah
R
Loyola University Chicago School of Law, USA.
D016915:AIDS Vaccines; D000349:Africa; D002986:Clinical Trials as Topic / Q000191:economics / Q000941:ethics*; D003906:Developing Countries; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control*; D006381:Helsinki Declaration; D006805:Human Experimentation / Q000941:ethics*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D007391:International Cooperation; D018570:Risk Assessment; D012935:Social Justice; D014481:United States; D015215:Zidovudine / Q000627:therapeutic use
D016915:AIDS Vaccines; D015215:Zidovudine